Reclast IV infusion solution 5mg, manufactured by Asahi Kasei Pharma, contains Zoledronic acid hydrate. This injectable drug, with YJ code 3999423A5023 and standard 5mg 100mL 1 bag, is a bisphosphonate available in a bag formulation for the treatment of osteoporosis, offering convenience in use.
Reclast IV infusion solution 5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →